Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Cancer Research UK Scotland Institute Garscube Estate Switchback Road Bearsden Glasgow, G61 1BD

  1. Events
  2. Venues
  3. Cancer Research UK Scotland Institute Garscube Estate Switchback Road Bearsden Glasgow, G61 1BD
Events at this venue
Today

ELRIG’s Scottish Forum

Scotland has a rich legacy of innovation and drug discovery, with breakthroughs like Fleming’s penicillin and Isaacs’ interferon continuing to impact the world today. Home [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top